CausalSentinel

Protein Dossier — KIAA1161 (Alpha-galactosidase MYORG)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.104 0.03 5.38e-04 Wald ratio 1 cis NA
Systolic blood pressure automated reading -0.0266 0.00829 0.00132 Wald ratio 1 cis NA
Weight -0.0213 0.00715 0.00295 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0613 0.0208 0.00315 Wald ratio 1 cis NA
Diagnoses - main ICD10: C61 Malignant neoplasm of prostate 0.218 0.0805 0.00685 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0659 0.0247 0.00756 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0967 0.0376 0.0102 Wald ratio 1 cis NA
Non-cancer illness code self-reported: iron deficiency anaemia 0.213 0.0905 0.0184 Wald ratio 1 cis NA
Body mass index (BMI) -0.0182 0.0081 0.0243 Wald ratio 1 cis NA
Diastolic blood pressure automated reading -0.0186 0.00829 0.0251 Wald ratio 1 cis NA
Amyotrophic lateral sclerosis 0.129 0.0591 0.0292 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0222 0.0105 0.0344 Wald ratio 1 cis NA
…and 70 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 78 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
bilateral striopallidodentate calcinosis 0.925 established (curated) no MR -> candidate analysis
Abnormality of the skeletal system 0.767 common-variant locus no MR -> candidate analysis
Basal ganglia calcification 0.438 established (curated) no MR -> candidate analysis
hereditary disease 0.243 established (curated) no MR -> candidate analysis
Dysarthria 0.195 established (curated) no MR -> candidate analysis
osteoarthritis, knee 0.195 common-variant locus no MR -> candidate analysis
total joint arthroplasty 0.195 common-variant locus no MR -> candidate analysis
osteoarthritis, hip 0.195 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.073 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.054 common-variant locus no MR -> candidate analysis
metabolic syndrome 0.047 common-variant locus no MR -> candidate analysis

Of the 11 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint not available
GWAS Catalog no mapped SNPs
ClinVar no records
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance